Tag Archives: Inc. (MRK)

fin-1

Merck & Co. Inc (MRK) Set to Acquire Cubist Pharmaceuticals Inc (CBST) for $7 Billion

Merck & Co. Inc (MRK) Set to Acquire Cubist Pharmaceuticals Inc (CBST) for $7 Billion

Merck & Co., Inc. (NYSE:MRK) is looking forward to acquiring Cubist Pharmaceuticals Inc (NASDAQ:CBST), an antibiotics maker, in a deal estimated to cost about $7 billion to $8 billion. A report by the Financial Times cited an unnamed source as saying that Merck will be paying Cubist around $102 per  share, with official announcements expected

Top